Skip to main content

Coagulation factor xa recombinant, inactivated-zhzo (Intravenous)

Generic name: coagulation factor xa recombinant, inactivated-zhzo [ koh-a-gyoo-LAY-shun-FAK-tor-TEN-A-re-KOM-bin-ant, in-AK-ti-vay-ted-- zhzo ]
Brand name: Andexxa
Drug class: Anticoagulant reversal agents

Medically reviewed by Drugs.com. Last updated on Aug 22, 2023.

Intravenous route(Powder for Solution)

Thromboembolic Risks, Ischemic Risks, Cardiac Arrest, and Sudden Deaths

Treatment with coagulation factor Xa (recombinant) IV injection has been associated with serious and life-threatening adverse events, including:

Arterial and venous thrombolic events

Ischemic events, including myocardial infarction and ischemic stroke

Cardiac arrest

Sudden deaths

Monitor for thromboembolic events and initiate anticoagulation when medically appropriate. Monitor for symptoms and signs that precede cardiac arrest and provide treatment as needed .

Uses for coagulation factor xa recombinant, inactivated-zhzo

Coagulation factor Xa (recombinant), inactivated-zhzo injection is used to treat life-threatening or uncontrolled bleeding in patients who are receiving other medicines (including apixaban and rivaroxaban).

This medicine is to be given only by or under the supervision of your doctor or other health care professional.

Before using coagulation factor xa recombinant, inactivated-zhzo

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of coagulation factor Xa (recombinant), inactivated-zhzo injection in the pediatric population. Safety and efficacy have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of coagulation factor Xa (recombinant), inactivated-zhzo injection in the elderly. However, elderly patients are more sensitive to the effects of this medicine than younger adults.

Breast Feeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Proper use of coagulation factor xa recombinant, inactivated-zhzo

A doctor or other trained health professional will give you this medicine in a medical facility. It is given through a needle placed into one of your veins.

Detailed Coagulation factor Xa dosage information

Precautions while using coagulation factor xa recombinant, inactivated-zhzo

It is very important that your doctor check you closely while you are receiving this medicine to make sure it is working properly. Blood tests will be needed to check for unwanted effects.

This medicine may increase your risk for blood clots, including stroke and heart attack, within 30 days of receiving the injection. Tell your doctor right away if you have a sudden or severe headache, problems with vision or speech, chest pain, shortness of breath, or numbness or weakness.

Side Effects of coagulation factor xa recombinant, inactivated-zhzo

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur:

More common

Less common

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Coagulation factor Xa side effects (more detail)

Commonly used brand name(s)

In the U.S.

Available Dosage Forms:

Therapeutic Class: Blood Modifier Agent

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer